HEADER TRANSFERASE 30-JUL-13 4LXX TITLE CRYSTAL STRUCTURE WLARD, A SUGAR 3N-FORMYL TRANSFERASE IN THE PRESENCE TITLE 2 OF DTDP-FUC3NFO AND 5-N-FORMYL-THF COMPND MOL_ID: 1; COMPND 2 MOLECULE: WLARD, A SUGAR 3N-FORMYL TRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI SUBSP. JEJUNI; SOURCE 3 ORGANISM_TAXID: 407148; SOURCE 4 STRAIN: 81116; SOURCE 5 GENE: C8J_1081; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS FMT, FORMYLTRANSFERASE, FORMYLATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.B.THODEN,M.-F.GONEAU,M.GILBERT,H.M.HOLDEN REVDAT 3 20-SEP-23 4LXX 1 REMARK SEQADV REVDAT 2 05-FEB-14 4LXX 1 JRNL REVDAT 1 14-AUG-13 4LXX 0 JRNL AUTH J.B.THODEN,M.F.GONEAU,M.GILBERT,H.M.HOLDEN JRNL TITL STRUCTURE OF A SUGAR N-FORMYLTRANSFERASE FROM CAMPYLOBACTER JRNL TITL 2 JEJUNI. JRNL REF BIOCHEMISTRY V. 52 6114 2013 JRNL REFN ISSN 0006-2960 JRNL PMID 23898784 JRNL DOI 10.1021/BI4009006 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 3 NUMBER OF REFLECTIONS : 124054 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6551 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 8150 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 423 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4511 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 211 REMARK 3 SOLVENT ATOMS : 764 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.43000 REMARK 3 B22 (A**2) : 0.51000 REMARK 3 B33 (A**2) : -1.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.064 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.068 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.042 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.072 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4954 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6725 ; 1.710 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 589 ; 7.802 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 245 ;38.029 ;25.837 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 905 ;13.971 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;14.812 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 750 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3676 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2803 ; 1.870 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4616 ; 2.814 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2151 ; 4.059 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2086 ; 6.096 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4LXX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081224. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 130605 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 56.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.12000 REMARK 200 R SYM FOR SHELL (I) : 0.12000 REMARK 200 FOR SHELL : 11.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4LXQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11-15% PEG 8000, 200 MM NACL, 5 MM N-5 REMARK 280 -FORMYL-THF, 5 MM TDP-FUC3NFO, PH 7, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.49600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.41250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.49600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.41250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 272 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 510 O HOH A 723 1.85 REMARK 500 O HOH B 452 O HOH B 635 1.90 REMARK 500 O HOH A 695 O HOH A 748 1.91 REMARK 500 O HOH B 601 O HOH B 737 1.93 REMARK 500 O HOH A 771 O HOH A 825 1.94 REMARK 500 O HOH B 556 O HOH B 661 1.97 REMARK 500 O HOH A 586 O HOH A 786 1.98 REMARK 500 O HOH A 677 O HOH A 762 2.01 REMARK 500 O HOH B 608 O HOH B 662 2.10 REMARK 500 O HOH B 597 O HOH B 736 2.14 REMARK 500 NZ LYS A 83 O HOH A 442 2.15 REMARK 500 O HOH A 742 O HOH A 773 2.15 REMARK 500 O HOH A 650 O HOH A 758 2.16 REMARK 500 O HOH A 670 O HOH B 705 2.16 REMARK 500 OD2 ASP B 42 O HOH B 651 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 5 CA - CB - SG ANGL. DEV. = 10.2 DEGREES REMARK 500 ARG B 215 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 10 -177.45 74.34 REMARK 500 TYR A 24 -51.65 -131.19 REMARK 500 SER A 43 -132.87 -130.21 REMARK 500 SER A 120 -156.61 -139.08 REMARK 500 ASN A 186 -6.57 74.00 REMARK 500 PHE A 219 84.32 -154.80 REMARK 500 ASN A 229 14.03 57.02 REMARK 500 ASN B 10 -176.33 74.14 REMARK 500 TYR B 24 -41.22 -137.46 REMARK 500 SER B 43 -128.22 -128.94 REMARK 500 SER B 43 -127.85 -129.29 REMARK 500 SER B 120 -157.67 -137.76 REMARK 500 ASN B 186 -5.20 73.72 REMARK 500 PHE B 219 84.63 -157.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B -1 HIS B 0 -139.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FON A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FNF A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FON B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FNF B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 308 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4LXQ RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH DTPD AND 5-N-FORMYL-THF REMARK 900 RELATED ID: 4LXT RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH DTPD-QUI3N AND 5-N-FORMYL-THF REMARK 900 RELATED ID: 4LXU RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH DTPD-FUC3N AND 5-N-FORMYL-THF REMARK 900 RELATED ID: 4LXY RELATED DB: PDB REMARK 900 RELATED ID: 4LY0 RELATED DB: PDB REMARK 900 RELATED ID: 4LY3 RELATED DB: PDB DBREF 4LXX A 1 272 UNP A8FMJ3 A8FMJ3_CAMJ8 1 272 DBREF 4LXX B 1 272 UNP A8FMJ3 A8FMJ3_CAMJ8 1 272 SEQADV 4LXX GLY A -1 UNP A8FMJ3 EXPRESSION TAG SEQADV 4LXX HIS A 0 UNP A8FMJ3 EXPRESSION TAG SEQADV 4LXX GLY B -1 UNP A8FMJ3 EXPRESSION TAG SEQADV 4LXX HIS B 0 UNP A8FMJ3 EXPRESSION TAG SEQRES 1 A 274 GLY HIS MET ILE LYS ILE CYS ILE ALA GLY LYS ASN ASN SEQRES 2 A 274 ILE ALA VAL ASN SER LEU GLN PHE ILE LEU LYS ASN TYR SEQRES 3 A 274 PHE GLU ALA ASP GLN ILE VAL VAL ILE PRO ASN LYS ASN SEQRES 4 A 274 ASP LYS GLY ILE ASP SER TRP GLN LYS SER LEU LEU LYS SEQRES 5 A 274 PHE ALA LEU ASP ASN ASN ILE LYS ILE VAL THR LEU ASP SEQRES 6 A 274 GLU ILE TYR ASN ILE GLU GLN ILE ILE PHE PHE SER LEU SEQRES 7 A 274 GLU PHE ASP GLN ILE ILE LYS ILE GLU ASN PHE LYS SER SEQRES 8 A 274 ASP ARG LEU PHE ASN ILE HIS PHE SER ALA LEU PRO LYS SEQRES 9 A 274 TYR LYS GLY VAL PHE THR SER ILE THR PRO ILE LEU ASN SEQRES 10 A 274 ASN GLU LEU GLU SER GLY VAL THR LEU HIS ARG ILE ASP SEQRES 11 A 274 ASN GLY ILE ASP THR GLY ASN ILE ILE ASP GLN HIS CYS SEQRES 12 A 274 PHE PRO ILE ASP ILE ASN ASP THR ALA ARG ASP LEU TYR SEQRES 13 A 274 PHE ASN TYR LEU LYS TYR GLY GLU SER ILE PHE LYS LYS SEQRES 14 A 274 ASN ILE GLN THR ILE ILE ASN ASN SER TYR LYS ASP LEU SEQRES 15 A 274 LYS GLN THR ASN ILE ASN SER SER TYR PHE SER ARG LYS SEQRES 16 A 274 ASP ILE ASN LEU VAL HIS LYS ILE ASN PHE LYS LYS THR SEQRES 17 A 274 SER PHE GLU ILE HIS ASN GLN ILE ARG ALA PHE ILE PHE SEQRES 18 A 274 GLN GLU TYR GLN LEU PRO ILE ILE ASN ASN SER LYS ILE SEQRES 19 A 274 ILE LYS SER ILE LEU ALA ASN GLU PHE ILE GLY TYR ASN SEQRES 20 A 274 VAL PHE GLU GLU PHE GLU ASN TYR PHE ILE ILE SER GLY SEQRES 21 A 274 ILE ASP GLY PHE LYS ILE ILE ALA GLN LYS LEU ASN LYS SEQRES 22 A 274 LEU SEQRES 1 B 274 GLY HIS MET ILE LYS ILE CYS ILE ALA GLY LYS ASN ASN SEQRES 2 B 274 ILE ALA VAL ASN SER LEU GLN PHE ILE LEU LYS ASN TYR SEQRES 3 B 274 PHE GLU ALA ASP GLN ILE VAL VAL ILE PRO ASN LYS ASN SEQRES 4 B 274 ASP LYS GLY ILE ASP SER TRP GLN LYS SER LEU LEU LYS SEQRES 5 B 274 PHE ALA LEU ASP ASN ASN ILE LYS ILE VAL THR LEU ASP SEQRES 6 B 274 GLU ILE TYR ASN ILE GLU GLN ILE ILE PHE PHE SER LEU SEQRES 7 B 274 GLU PHE ASP GLN ILE ILE LYS ILE GLU ASN PHE LYS SER SEQRES 8 B 274 ASP ARG LEU PHE ASN ILE HIS PHE SER ALA LEU PRO LYS SEQRES 9 B 274 TYR LYS GLY VAL PHE THR SER ILE THR PRO ILE LEU ASN SEQRES 10 B 274 ASN GLU LEU GLU SER GLY VAL THR LEU HIS ARG ILE ASP SEQRES 11 B 274 ASN GLY ILE ASP THR GLY ASN ILE ILE ASP GLN HIS CYS SEQRES 12 B 274 PHE PRO ILE ASP ILE ASN ASP THR ALA ARG ASP LEU TYR SEQRES 13 B 274 PHE ASN TYR LEU LYS TYR GLY GLU SER ILE PHE LYS LYS SEQRES 14 B 274 ASN ILE GLN THR ILE ILE ASN ASN SER TYR LYS ASP LEU SEQRES 15 B 274 LYS GLN THR ASN ILE ASN SER SER TYR PHE SER ARG LYS SEQRES 16 B 274 ASP ILE ASN LEU VAL HIS LYS ILE ASN PHE LYS LYS THR SEQRES 17 B 274 SER PHE GLU ILE HIS ASN GLN ILE ARG ALA PHE ILE PHE SEQRES 18 B 274 GLN GLU TYR GLN LEU PRO ILE ILE ASN ASN SER LYS ILE SEQRES 19 B 274 ILE LYS SER ILE LEU ALA ASN GLU PHE ILE GLY TYR ASN SEQRES 20 B 274 VAL PHE GLU GLU PHE GLU ASN TYR PHE ILE ILE SER GLY SEQRES 21 B 274 ILE ASP GLY PHE LYS ILE ILE ALA GLN LYS LEU ASN LYS SEQRES 22 B 274 LEU HET FON A 301 34 HET MPO A 302 13 HET MPO A 303 13 HET FNF A 304 37 HET CL A 305 1 HET FON B 301 34 HET MPO B 302 13 HET MPO B 303 13 HET FNF B 304 37 HET EDO B 305 4 HET EDO B 306 4 HET EDO B 307 4 HET EDO B 308 4 HETNAM FON N-{[4-({[(6R)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8- HETNAM 2 FON HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)PHENYL]CARBONYL}- HETNAM 3 FON L-GLUTAMIC ACID HETNAM MPO 3[N-MORPHOLINO]PROPANE SULFONIC ACID HETNAM FNF (2R,3R,4S,5R,6R)-4-(FORMYLAMINO)-3,5-DIHYDROXY-6- HETNAM 2 FNF METHYLTETRAHYDRO-2H-PYRAN-2-YL [(2R,3S,5R)-3-HYDROXY- HETNAM 3 FNF 5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) HETNAM 4 FNF TETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN DIPHOSPHATE HETNAM 5 FNF (NON-PREFERRED NAME) HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN FON [6R]-5-FORMYL-5,6,7,8-TETRAHYDROFOLATE; 6R-FOLINIC ACID HETSYN EDO ETHYLENE GLYCOL FORMUL 3 FON 2(C20 H23 N7 O7) FORMUL 4 MPO 4(C7 H15 N O4 S) FORMUL 6 FNF 2(C17 H27 N3 O15 P2) FORMUL 7 CL CL 1- FORMUL 12 EDO 4(C2 H6 O2) FORMUL 16 HOH *764(H2 O) HELIX 1 1 LYS A 9 TYR A 24 1 16 HELIX 2 2 GLU A 26 ASP A 28 5 3 HELIX 3 3 SER A 47 ASN A 55 1 9 HELIX 4 4 THR A 61 TYR A 66 1 6 HELIX 5 5 LYS A 83 PHE A 87 5 5 HELIX 6 6 ILE A 110 ASN A 115 1 6 HELIX 7 7 THR A 149 ASN A 174 1 26 HELIX 8 8 SER A 191 ILE A 195 5 5 HELIX 9 9 THR A 206 ALA A 216 1 11 HELIX 10 10 LYS B 9 TYR B 24 1 16 HELIX 11 11 GLU B 26 ASP B 28 5 3 HELIX 12 12 SER B 47 ASN B 55 1 9 HELIX 13 13 LYS B 83 PHE B 87 5 5 HELIX 14 14 ILE B 110 ASN B 115 1 6 HELIX 15 15 THR B 149 ASN B 174 1 26 HELIX 16 16 SER B 191 ILE B 195 5 5 HELIX 17 17 THR B 206 ALA B 216 1 11 SHEET 1 A 7 LYS A 58 ILE A 59 0 SHEET 2 A 7 ILE A 30 PRO A 34 1 N VAL A 32 O LYS A 58 SHEET 3 A 7 ILE A 4 GLY A 8 1 N ILE A 6 O VAL A 31 SHEET 4 A 7 ILE A 72 LEU A 76 1 O ILE A 72 N CYS A 5 SHEET 5 A 7 ARG A 91 HIS A 96 1 O PHE A 93 N SER A 75 SHEET 6 A 7 GLU A 119 ARG A 126 -1 O THR A 123 N HIS A 96 SHEET 7 A 7 ILE A 136 PRO A 143 -1 O ILE A 137 N LEU A 124 SHEET 1 B 2 LYS A 104 GLY A 105 0 SHEET 2 B 2 TYR A 189 PHE A 190 1 O PHE A 190 N LYS A 104 SHEET 1 C 5 ILE A 226 ILE A 227 0 SHEET 2 C 5 SER A 230 PHE A 241 -1 O SER A 230 N ILE A 227 SHEET 3 C 5 PHE A 262 LYS A 268 -1 O LYS A 263 N ALA A 238 SHEET 4 C 5 TYR A 253 ILE A 256 -1 N ILE A 256 O ILE A 264 SHEET 5 C 5 PHE A 247 GLU A 249 -1 N GLU A 248 O ILE A 255 SHEET 1 D 7 LYS B 58 ILE B 59 0 SHEET 2 D 7 ILE B 30 PRO B 34 1 N VAL B 32 O LYS B 58 SHEET 3 D 7 ILE B 4 GLY B 8 1 N ILE B 4 O VAL B 31 SHEET 4 D 7 ILE B 72 LEU B 76 1 O LEU B 76 N ALA B 7 SHEET 5 D 7 ARG B 91 HIS B 96 1 O ARG B 91 N PHE B 73 SHEET 6 D 7 GLU B 119 ARG B 126 -1 O THR B 123 N HIS B 96 SHEET 7 D 7 ILE B 136 PRO B 143 -1 O ILE B 137 N LEU B 124 SHEET 1 E 2 LYS B 104 GLY B 105 0 SHEET 2 E 2 TYR B 189 PHE B 190 1 O PHE B 190 N LYS B 104 SHEET 1 F 5 ILE B 226 ILE B 227 0 SHEET 2 F 5 SER B 230 PHE B 241 -1 O SER B 230 N ILE B 227 SHEET 3 F 5 PHE B 262 LYS B 268 -1 O LYS B 263 N ALA B 238 SHEET 4 F 5 TYR B 253 ILE B 256 -1 N ILE B 256 O ILE B 264 SHEET 5 F 5 PHE B 247 GLU B 249 -1 N GLU B 248 O ILE B 255 CISPEP 1 LEU A 100 PRO A 101 0 17.19 CISPEP 2 LEU B 100 PRO B 101 0 14.14 SITE 1 AC1 20 SER A 75 PHE A 78 GLN A 80 ILE A 81 SITE 2 AC1 20 ILE A 82 ASN A 94 HIS A 125 ILE A 127 SITE 3 AC1 20 ASP A 128 ASN A 129 GLY A 130 ASP A 132 SITE 4 AC1 20 SER A 191 ARG A 192 FNF A 304 HOH A 403 SITE 5 AC1 20 HOH A 439 HOH A 456 HOH A 820 EDO B 305 SITE 1 AC2 7 PHE A 203 ILE A 227 ASN A 228 PHE A 247 SITE 2 AC2 7 HOH A 489 HOH A 528 HOH A 576 SITE 1 AC3 10 ILE A 84 ASP A 128 ASN A 129 ASN A 135 SITE 2 AC3 10 HOH A 485 HOH A 547 HOH A 722 PHE B 241 SITE 3 AC3 10 TYR B 244 HOH B 493 SITE 1 AC4 28 LYS A 9 GLU A 77 PHE A 78 ASN A 94 SITE 2 AC4 28 HIS A 96 GLY A 105 VAL A 106 PHE A 107 SITE 3 AC4 28 THR A 108 SER A 109 ASP A 132 TYR A 154 SITE 4 AC4 28 ARG A 192 LEU A 197 PHE A 219 TYR A 222 SITE 5 AC4 28 GLN A 223 FON A 301 HOH A 418 HOH A 422 SITE 6 AC4 28 HOH A 429 HOH A 467 HOH A 481 HOH A 510 SITE 7 AC4 28 HOH A 569 HOH A 696 HOH A 751 HOH A 753 SITE 1 AC5 4 ARG A 126 ASN A 135 HOH A 485 HOH A 624 SITE 1 AC6 18 SER B 75 PHE B 78 GLN B 80 ILE B 81 SITE 2 AC6 18 ILE B 82 ASN B 94 HIS B 125 ILE B 127 SITE 3 AC6 18 ASP B 128 ASN B 129 GLY B 130 ASP B 132 SITE 4 AC6 18 SER B 191 ARG B 192 FNF B 304 HOH B 457 SITE 5 AC6 18 HOH B 497 HOH B 498 SITE 1 AC7 8 PHE B 203 ILE B 227 ASN B 228 PHE B 247 SITE 2 AC7 8 HOH B 490 HOH B 495 HOH B 544 HOH B 630 SITE 1 AC8 9 PHE A 241 TYR A 244 ASP B 128 ASN B 129 SITE 2 AC8 9 ASN B 135 HOH B 412 HOH B 518 HOH B 565 SITE 3 AC8 9 HOH B 714 SITE 1 AC9 25 LYS B 9 GLU B 77 PHE B 78 ASN B 94 SITE 2 AC9 25 HIS B 96 GLY B 105 VAL B 106 PHE B 107 SITE 3 AC9 25 THR B 108 SER B 109 ASP B 132 TYR B 154 SITE 4 AC9 25 ARG B 192 LEU B 197 PHE B 219 TYR B 222 SITE 5 AC9 25 GLN B 223 FON B 301 HOH B 404 HOH B 426 SITE 6 AC9 25 HOH B 519 HOH B 575 HOH B 576 HOH B 646 SITE 7 AC9 25 HOH B 729 SITE 1 BC1 5 ILE A 131 FON A 301 ASN B 245 ILE B 259 SITE 2 BC1 5 HOH B 423 SITE 1 BC2 5 ARG B 151 GLN B 220 GLU B 221 HOH B 439 SITE 2 BC2 5 HOH B 712 SITE 1 BC3 6 TRP B 44 ARG B 151 LEU B 269 LYS B 271 SITE 2 BC3 6 LEU B 272 HOH B 597 SITE 1 BC4 7 ILE A 242 HOH A 613 HOH A 674 PHE B 241 SITE 2 BC4 7 GLY B 243 HOH B 493 HOH B 718 CRYST1 96.992 64.825 134.798 90.00 110.60 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010310 0.000000 0.003876 0.00000 SCALE2 0.000000 0.015426 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007925 0.00000